Gangotri Textiles Limited (NSE:GANGOTRI)

CTI BioPharma Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Other Revenue	-	-	-	-	0.56	-
Revenue	-	-	-	-	0.56	-
Gross Profit	-	-	-	-	0.56	-
Selling, General & Admin	0.08	0.08	0.09	0.07	0.08	0.13
Other Operating Expenses	0.62	0.64	0.65	0.59	0.75	0.7
Operating Expenses	0.7	0.72	0.75	0.67	0.84	0.83
Operating Income	-0.7	-0.72	-0.75	-0.67	-0.28	-0.83
Other Non Operating Income (Expenses)	-	-	-	-	-	0.5
EBT Excluding Unusual Items	-0.7	-0.72	-0.75	-0.67	-0.28	-0.33
Pretax Income	-0.7	-0.72	-0.75	-0.67	-0.28	-0.33
Income Tax Expense	-	-	-	7.91	-	-
Net Income	-0.7	-0.72	-0.75	-8.57	-0.28	-0.33
Net Income to Common	-0.7	-0.72	-0.75	-8.57	-0.28	-0.33
Shares Outstanding (Basic)	33	33	33	33	33	33
Shares Outstanding (Diluted)	33	33	33	33	33	33
EPS (Basic)	-0.02	-0.02	-0.02	-0.26	-0.01	-0.01
EPS (Diluted)	-0.02	-0.02	-0.02	-0.26	-0.01	-0.01
Free Cash Flow	-	-0.71	-0.74	-0.76	-0.29	-0.4
Free Cash Flow Per Share	-	-0.02	-0.02	-0.02	-0.01	-0.01
Gross Margin	-	-	-	-	100.00%	-
Operating Margin	-	-	-	-	-49.78%	-
Profit Margin	-	-	-	-	-49.78%	-
Free Cash Flow Margin	-	-	-	-	-51.21%	-
EBITDA	-0.7	-0.71	-0.75	-0.66	-0.27	-0.83
EBITDA Margin	-	-	-	-	-49.13%	-
D&A For EBITDA	0	0	0	0	0	0
EBIT	-0.7	-0.72	-0.75	-0.67	-0.28	-0.83
EBIT Margin	-	-	-	-	-49.78%	-
Revenue as Reported	-	-	-	-	0.56	0.5
Advertising Expenses	-	0.06	0.08	-	-	-

Updated Jan 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.